Carregant...

Evaluating the Combined Effect of Comorbidity and Prostate-Specific Antigen Kinetics on the Risk of Death in Men After Prostate-Specific Antigen Recurrence

PURPOSE: We examined whether time-dependent continuous prostate-specific antigen (PSA) velocity at recurrence was associated with all cause mortality (ACM) adjusting for comorbidity levels among men treated with definitive radiation therapy (RT) alone with or without androgen suppression therapy (AS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Wo, Jennifer Y., Chen, Ming-Hui, Nguyen, Paul L., Renshaw, Andrew A., Loffredo, Marian J., Kantoff, Philip W., D'Amico, Anthony V.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057277/
https://ncbi.nlm.nih.gov/pubmed/19858385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.6067
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!